Anemia, Hemorrhage, and Transfusion in Percutaneous Coronary Intervention, Acute Coronary Syndromes, and ST-Segment Elevation Myocardial Infarction

This publication has 20 references indexed in Scilit:

• Effect of Anemia on Hemorrhagic Complications and Mortality Following Percutaneous Coronary Intervention
  The American Journal of Cardiology, 2007
• Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions
  The American Journal of Cardiology, 2004
• Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the controlled abciximab and device investigation to lower late angioplasty complications (cadillac) trial
  Published by Elsevier ,2004
• Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention
  Circulation, 2004
• Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)
  European Heart Journal, 2003
• Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention
  JAMA, 2003
• Blood Transfusion in Elderly Patients with Acute Myocardial Infarction
  New England Journal of Medicine, 2001
• Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
  Critical Care Medicine, 2001
• Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non–ST-Elevation Acute Coronary Syndromes
  Circulation, 1999
• An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
  New England Journal of Medicine, 1993